Reduced
susceptibility to antimicrobials in Gram-negative bacteria may result
from multiple resistance mechanisms, including increased efflux pump
activity or reduced porin protein expression. Up-regulation of the
efflux pump system is closely associated with multidrug resistance
(MDR). To help investigate the role of efflux pumps on compound accumulation,
a fluorescence-based assay was developed using fluorescent derivatives
of trimethoprim (TMP), a broad-spectrum synthetic antibiotic that
inhibits an intracellular target, dihydrofolate reductase (DHFR).
Novel fluorescent TMP probes inhibited eDHFR activity
with comparable potency to TMP, but did not kill or inhibit growth
of wild type Escherichia coli. However,
bactericidal activity was observed against an efflux pump deficient E. coli mutant strain (ΔtolC). A simple and quick fluorescence assay was developed to measure
cellular accumulation of the TMP probe using either fluorescence spectroscopy
or flow cytometry, with validation by LC-MS/MS. This fluorescence
assay may provide a simple method to assess efflux pump activity with
standard laboratory equipment.